Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel disease

Alicia Algaba,Sara Romero,Alicia Granja,Daniel Garza,Mar Aller, Sara Barrero,Iván Guerra,Marina Gil, Nazaret Pizarro,Paloma Ruiz,Santiago Prieto,Belén Hernández, Aranzazu Pou,Fernando Bermejo

Gastroenterología y Hepatología (English Edition)（2023）

引用 0|浏览6

暂无评分

摘要

One third of patients with IBD did not develop antibodies with the initial vaccination against SARS-CoV-2. The SR to vaccines based on mRNA technology was higher, and it was related to age (higher in younger patients). Immunosuppressants and biologicals did not decrease SR. More than half of the patients presented AD, being mild in all cases.

查看译文

关键词

Inflammatory bowel disease,SARS-CoV-2 vaccine,COVID-19,Biologicals

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要